Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer

NCT00865982 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Esophageal Cancer

Interventions

DRUG: Docetaxel, Cisplatin, Capecitabine

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]
[object Object]